CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Single-Arm Multi-Center Trial Evaluating the Efficacy of Pembrolizumab in the Treatment of Subjects With Incurable Platinum-Refractory Germ Cell Tumors: Hoosier Cancer Research Network GU14-206

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02499952
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:35.493039+00:00
Published At: 2018-04-17T00:00:00+00:00
Record Updated At: 2022-07-11
Results Posted At: 2018-04-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Germ Cell Neoplasms", "Testicular Neoplasms", "Non Seminomatous Germ Cell Tumors", "Mediastinal Neoplasms", "Genital Neoplasms, Male", "Genital Neoplasms, Female", "Ovarian Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-07-11"
protocolSection.identificationModule.nctId: "NCT02499952"
protocolSection.identificationModule.officialTitle: "A Phase II Single-Arm Multi-Center Trial Evaluating the Efficacy of Pembrolizumab in the Treatment of Subjects With Incurable Platinum-Refractory Germ Cell Tumors: Hoosier Cancer Research Network GU14-206"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-04-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.